{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:28:45Z","timestamp":1791203325699,"version":"4.2.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009896","name":"Indian Institute of Technology (Indian School of Mines), Dhanbad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005808","name":"Indian Institute of Technology Bombay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004891","name":"IIlinois State Museum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.136977","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T07:17:23Z","timestamp":1730099843000},"page":"136977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P3","title":["In silico screening and identifying phytoconstituents of Withania somnifera as potent inhibitors of BRCA1 mutants: A therapeutic against breast cancer"],"prefix":"10.1016","volume":"282","author":[{"given":"Smita Manjari","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nandeshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umakanta","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.136977_bb0005","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0010","first-page":"369","article-title":"The importance of BRCA1 and BRCA2 genes mutations in breast cancer development","volume":"30","author":"Mehrgou","year":"2016","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6603535","article-title":"Cancer risks among BRCA1 and BRCA2 mutation carriers","volume":"96","author":"Levy-Lahad","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136977_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136977_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2","volume":"12","author":"Petrucelli","year":"2010","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136977_bb0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.onc.1203269","article-title":"Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation","volume":"19","author":"Deng","year":"2000","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136977_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4143\/crt.2004.36.4.214","article-title":"DNA damage response mediated through BRCA1","volume":"36","author":"Jang","year":"2004","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0045","series-title":"BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer","author":"Petrucelli","year":"1998"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0050","article-title":"BRCA1 and BRCA2 mutations and treatment strategies for breast cancer","volume":"4","author":"Godet","year":"2017","journal-title":"Integr. Cancer Sci. Ther."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.136977_bb0055","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3390\/cancers14235953","article-title":"Gastric Cancer risk and pathogenesis in BRCA1 and BRCA2 carriers","volume":"14","author":"Buckley","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0060","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3390\/cimb45030135","article-title":"The landscape and therapeutic targeting of BRCA1, BRCA2 and other DNA damage response genes in pancreatic Cancer","author":"Voutsadakis","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102668","article-title":"How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?","volume":"81","author":"Venkitaraman","year":"2019","journal-title":"DNA Repair"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.136977_bb0070","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1021\/bi2003795","article-title":"Impact of BRCA1 BRCT domain missense substitutions on Phosphopeptide recognition","volume":"50","author":"Coquelle","year":"2011","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136977_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(96)01312-9","article-title":"From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair","volume":"400","author":"Callebaut","year":"1997","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0085","doi-asserted-by":"crossref","DOI":"10.5936\/csbj.201204005","article-title":"Structure-function of the tumor suppressor BRCA1","volume":"1","author":"Clark","year":"2012","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0090","doi-asserted-by":"crossref","DOI":"10.5936\/csbj.201204005","article-title":"Structure-function of the tumor suppressor BRCA1","volume":"1","author":"Clark","year":"2012","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136977_bb0095","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","article-title":"Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136977_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"the International Natural Product Sciences, Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136977_bb0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0110","article-title":"Computational exploration of Picrasma quassioides compounds as CviR-mediated quorum sensing inhibitors against Chromobacterium violaceum","volume":"12","author":"Revanasiddappa","year":"2024"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136977_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275432","article-title":"Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: investigations through computational, molecular docking and conceptual DFT studies","volume":"17","author":"Gowtham","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0120","doi-asserted-by":"crossref","first-page":"22446","DOI":"10.1038\/s41598-022-22038-x","article-title":"Integrated approach for studying bioactive compounds from Cladosporium spp. against estrogen receptor alpha as breast cancer drug target","volume":"12","author":"Anandan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0125","unstructured":"n. Nandeshwar, J. Rout, S.M. Panda, U. Tripathy, Phytoconstituents of Ashwagandha as potential inhibitors of human islet amyloid polypeptide (hIAPP): an in silico investigation, J. Biomol. Struct. Dyn. 1\u201317."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136977_bb0130","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"IMPPAT 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants, ACS","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"Omega"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0135","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","article-title":"IMPPAT: A curated database of Indian medicinal plants, Phytochemistry and therapeutics","volume":"8","author":"Mohanraj","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0150","first-page":"33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Chemother."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136977_bb0155","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple Ligand\u2013Protein Interaction Diagrams for Drug Discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0160","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136977_bb0165","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.136977_bb0175","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136977_bb0180","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM general force Field (CGenFF) I: bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.136977_bb0185","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0190","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular-dynamics with coupling to an external Bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136977_bb0195","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136977_bb0200","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.136977_bb0205","doi-asserted-by":"crossref","first-page":"12221","DOI":"10.1080\/07391102.2021.1969282","article-title":"Gonzales iii, in-silico screening and identification of phytochemicals from Centella asiatica as potential inhibitors of sodium-glucose co-transporter 2 for treating diabetes","volume":"40","author":"Macalalad","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136977_bb0210","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.136977_bb0215","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1039\/D4RA00819G","article-title":"In silico identification of multi-target inhibitors from medicinal fungal metabolites against the base excision repair pathway proteins of African swine fever virus","volume":"14","author":"Macalalad","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0220","series-title":"Comprehensive Medicinal Chemistry II","first-page":"531","article-title":"5.22 - use of molecular descriptors for absorption, distribution, metabolism, and excretion predictions","author":"Winiwarter","year":"2007"},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0225","series-title":"Concepts and Experimental Protocols of Modelling and Informatics in Drug Design","first-page":"299","article-title":"Chapter 14 - ADMET tools: Prediction and assessment of chemical ADMET properties of NCEs","author":"Silakari","year":"2021"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136977_bb0230","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/molecules24081505","article-title":"Lipophilicity as a central component of drug-like properties of Chalchones and flavonoid derivatives","volume":"24","author":"Constantinescu","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136977_bb0235","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: A simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136977_bb0240","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1021\/ci700257y","article-title":"Computation of octanol\u2212water partition coefficients by guiding an additive model with knowledge","volume":"47","author":"Cheng","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0245","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/ci990307l","article-title":"Prediction of physicochemical parameters by atomic contributions","volume":"39","author":"Wildman","year":"1999","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0250","series-title":"Simple Method of Calculating Octanol\/Water Partition Coefficient","first-page":"127","volume":"40","author":"Moriguchi","year":"1992"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136977_bb0255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0260","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/195727","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136977_bb0265","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/jpet.119.257113","article-title":"Pharmacokinetic and Pharmacodynamic properties of drug delivery systems","volume":"370","author":"Patrick","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0270","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jmb.2008.10.018","article-title":"Principal component analysis for protein folding dynamics","volume":"385","author":"Maisuradze","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0275","doi-asserted-by":"crossref","first-page":"1133472","DOI":"10.3389\/fcell.2023.1133472","article-title":"Targeting the BRCA1\/2 deficient cancer with PARP inhibitors: clinical outcomes and mechanistic insights","volume":"11","author":"Ragupathi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136977_bb0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11010-021-04338-4","article-title":"Screening and identification of phytochemical drug molecules against mutant BRCA1 receptor of breast cancer using computational approaches","volume":"477","author":"Singh","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136977_bb0285","first-page":"167","article-title":"Olaparib: A novel therapy for metastatic breast Cancer in patients with a BRCA1\/2 mutation","volume":"10","author":"Caulfield","year":"2019","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0290","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212540","article-title":"Advances in the use of PARP inhibitor therapy for breast cancer","volume":"7","author":"McCann","year":"2018","journal-title":"Drugs Context"},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.136977_bb0295","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2217\/fon-2018-0751","article-title":"Advances in the use of PARP inhibitors for BRCA1\/2-associated breast cancer: talazoparib","volume":"15","author":"McCann","year":"2019","journal-title":"Future Oncol."},{"issue":"null","key":"10.1016\/j.ijbiomac.2024.136977_bb0300","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/DDDT.S130809","article-title":"Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer","volume":"12","author":"Colombo","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"98","key":"10.1016\/j.ijbiomac.2024.136977_bb0305","doi-asserted-by":"crossref","first-page":"37080","DOI":"10.18632\/oncotarget.26354","article-title":"A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models","volume":"9","author":"Sun","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.08.004","article-title":"Withaferin A: from ayurvedic folk medicine to preclinical anti-cancer drug","volume":"173","author":"Hassannia","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136977_bb0315","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/mnfr.201500756","article-title":"Withania somnifera: from prevention to treatment of cancer","volume":"60","author":"Palliyaguru","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.procbio.2021.09.007","article-title":"Molecular modeling studies of the effects of withaferin A and its derivatives against oncoproteins associated with breast cancer stem cell activity","volume":"111","author":"Mallavarpu Ambrose","year":"2021","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110383","article-title":"Withaferin A suppresses breast cancer cell proliferation by inhibition of the two-pore domain potassium (K2P9) channel TASK-3","volume":"129","author":"Z\u00fa\u00f1iga","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112769","article-title":"Neurodegenerative diseases and Withania somnifera (L.): an update","volume":"256","author":"Dar","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136977_bb0335","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/molecules28041588","article-title":"In silico computational studies of bioactive secondary metabolites from Wedelia trilobata against anti-apoptotic B-cell Lymphoma-2 (Bcl-2) protein associated with Cancer cell survival and resistance","volume":"28","author":"Gowtham","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136977_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296010","article-title":"Secondary metabolites of Trichoderma spp. as EGFR tyrosine kinase inhibitors: evaluation of anti-cancer efficacy through computational approach","volume":"19","author":"Gowtham","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2024.136977_bb0345","series-title":"Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies, Molecules","author":"Murali","year":"2022"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024077869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024077869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:08:59Z","timestamp":1782900539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024077869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":69,"alternative-id":["S0141813024077869"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136977","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico screening and identifying phytoconstituents of Withania somnifera as potent inhibitors of BRCA1 mutants: A therapeutic against breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"136977"}}